TEPADINA
These highlights do not include all the information needed to use TEPADINA® safely and effectively. See full prescribing information for TEPADINA®. TEPADINA® (thiotepa) for injection, for intravenous, intracavitary, or intravesical use. nitial U.S. Approval: 1959 TEPADINA® (thiotepa) for injection, for intravenous, intracavitary, or intravesical use. Initial U.S. Approval: 1959
559e353c-2dc0-16ba-e054-00144ff8d46c
HUMAN PRESCRIPTION DRUG LABEL
Mar 27, 2020
Amneal Pharmaceuticals LLC
DUNS: 827748190
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
thiotepa
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
THIOTEPA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
THIOTEPA
Product Details
FDA regulatory identification and product classification information